AI Science Tracker
EN

Learned immune phenotypes associate with lung cancer survival

Fudan University; Zhongshan Hospital · 18 Mar 2020 · medicine

Discovery

Learned immune phenotypes associate with lung cancer survival

Source check: Source checked. Not independent scientific confirmation.

Finding: Unsupervised clustering identified two lung-adenocarcinoma immune-expression patterns, and a random forest assigned tumors in additional cohorts. The more immune-infiltrated pattern was associated with better overall survival, including in external gene-expression datasets. This observational classification does not establish treatment response or a causal protective effect of immune infiltration; immunotherapy outcomes were not available for validation.

Technology: Consensus unsupervised clustering; random forest

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Unsupervised clustering learns infiltration patterns and a random forest transfers those patterns to additional cohorts for clinical survival-association analysis.
Test and result
Expression-derived phenotypes in 514 TCGA tumors, with classifier assignment and survival comparisons in 1,063 GEO tumors and a 34-patient institutional cohort.
Limitation / still unknown
Prospective treatment-response utility and causal biology remain unestablished; immune-cell abundance is inferred from bulk expression and aggregate patient totals differ between the abstract and full text.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11027644/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.